Biological Heterogeneity of Diffuse Mixed Small and Large Cell Non-Hodgkin's Lymphomas Assessed by DNA Flow Cytometry and Ki67

References

• Dorfman R. E., Burke J. S., Berard C. W. A new working formulation on non-Hodgkin's lymphomas: Background, recommendations, histologic criteria, and relationship to other classifications. Advances in Malignant Lymphomas. Proceedings of third Annual Bristol Meyers Symposium on Cancer Research. Academic Press, New York 1981
   Google Scholar
• The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: Summary and description of Working Formulation for clinical usage. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Brylan R. C., Diamond L. W., Powell M. L., Harty-Golder B. Percentage of cells in the S phase of the cell cycle in human lymphoma determined by flow cytometry: Correlation with labelling index and patient survival. Cytometry 1980; 1: 171–174
   PubMedGoogle Scholar
• Hansen H., Kosiner B., Clarkson B. Marker and kinetic studies in non-Hodgkin's lymphomas. Am. J. Med 1981; 71: 107–123
   PubMed Web of Science ®Google Scholar
• Diamond L. W., Nathwani B. N., Rappaport H. Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia. Cancer 1982; 50: 1122–1125
   PubMed Web of Science ®Google Scholar
• Shackney S. E., Levine A. M., Fisher R. I. The biology of tumor growth in the non-Hodgkin's lymphomas. J. Clin. Invest 1984; 73: 1201–1214
   PubMed Web of Science ®Google Scholar
• Roos G., Dige U., Lenner P., Lindh J., Johansonn H. Prognostic significance of DNA analysis by flow cytometry in non-Hodgkin'S lymphoma. Hematol, Oncol. 1985; 1: 233–242
   Web of Science ®Google Scholar
• Cavalli C., Danuva M., Gobbi P. G., Riccardi A., Magrini U., Mazzini G., Rutigliano D., Bertolini L., Rossi A., Ascari E. Ploidy and proliferative activity measurement by flow cytometry in non-Hodgkin's lymphomas. Do speculative aspects prevail over clinical ones?. Eur. J. Cancer Clin. Oncol. 1989; 25: 1755–1763
   PubMedGoogle Scholar
• Cowan R. A., Harris M., Jones M., Crowther D. DNA. content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations. Br. J Cancer 1989; 60: 904–910
   PubMed Web of Science ®Google Scholar
• Macartney J. C, Camplejohn R. S. DNA flow cytometry of non-Hodgkin's lymphomas. Eur. J. Cancer 1990; 26: 635–637
   PubMed Web of Science ®Google Scholar
• Macartney J. C., Camplejohn R. S., Morris R., Hollowood K., Clarke D., Timothy A. DNA flow cytometry of follicular non-Hodgkin's lymplhoma. J. Clin. Pathol. 1991; 44: 215–218
   PubMed Web of Science ®Google Scholar
• Kvaloy S., Godal T., Marton P. F., Steen H., Brennhoved I. O., Abrahamsen A. F. Spontaneous [3H] thymidine uptake by histological subgroups of human B cell lymphomas. Scand. J. Haematol. 1981; 26: 221–234
   PubMedGoogle Scholar
• Kvaloy S., Morton P. F., Klaaus O., Hoie J., Foss-Abrahamsen A., Godal T. [3H] thymidine uptake in B cell lymphomas. Relationship to treatment response and survival. Scand. J. Haematol. 1985; 34: 429–435
   PubMedGoogle Scholar
• Silvestrini R., Piazza R., Riccardi A., Rilke F. Correlation of kinetic findings with norphology of non-Hodgkin's lymphomas. J Natl. Cancer Inst. 1977; 58: 499–504
   PubMed Web of Science ®Google Scholar
• Costa A., Bonadonna G., Villa E., Valagussa P., Silvestrini R. Labelling index as a prognostic marker in non-Hodgkin's lymphoma. J Natl. Cancer Inst. 1981; 66: 1–5
   PubMed Web of Science ®Google Scholar
• Hall P. A., Richards M. A., Gregory W. M., d'Ardenne A. J., Lister T. A., Stansfeld A. G. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol. 1988; 154: 223–235
   PubMed Web of Science ®Google Scholar
• Lardelli P., Bookman M. A., Sundeen J., Lingo D. L., Jaffe E. S. Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am J. Surg. Pathol. 1990; 14: 752–763
   PubMed Web of Science ®Google Scholar
• Brons P. P., Raemaekers J. M., Bogman M. J., Van Ert P. E., Boezeman J. B., Pennings A. H., Wessels H. M., Haanen C. Cell cycle kinetic, in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry. Blood 1992; 80: 2336–2343
   PubMed Web of Science ®Google Scholar
• Yamanaka N., Harabuchi Y., Kataura A. The prognostic value of Ki-67 antigen in non-Hodgkin's lymphoma of Waldeyer ring and nasal cavity. Cancer 1992; 70: 2342–2349
   PubMed Web of Science ®Google Scholar
• Gerard-Marchant R., Hamlin I., Lennert K., Rilke F., Stansfeld A. C., van Unnik J. A. M. Classification of now Hodgkin's lymphomas. [letter to the Editor]. Lancet 1974; 11: 406–408
   Google Scholar
• Stansfeld A. G., Diebold J., Kapanci Y., Keleny G., Lennert K., Mioduszewska O., Noel H., Rilke F., Sundstrom C., van Unnik J. A. M., Wright D. H. Updated Kiel Classification for lymphomas [letter to the Editor]. Lancet 1988; 1: 292–293
   PubMed Web of Science ®Google Scholar
• Vindelov L. L., Christensen I. J., Jensen G., Nissen N. I. Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Cytometry 1983; 3: 332–339
   PubMedGoogle Scholar
• Joensuu H., Klemi P. J. Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma. Am. J. Clin. Pathol 1988; 89: 35–40
   PubMed Web of Science ®Google Scholar
• Hsu S. M., Raine L., Franger H. Use of avidin-biotiri-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedure. J. Histochem. Cytochem 1981; 29: 577–580
   PubMed Web of Science ®Google Scholar
• Pich A., Ponti R., Valente C., Chiusa L., Geuna M., Novero D., Palestro G. MIB-I, K167, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. J. Clin. Pathol 1994; 47: 18–22
   PubMed Web of Science ®Google Scholar
• Ackerman M., Brandt L., Johnson A., Olsson H. Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis. Br. J. Cancer. 1987; 55: 219–223
   PubMed Web of Science ®Google Scholar
• Braylan R. C., Fowlkes B. S., Jaffe E. S., Sanders S. K., Berard C. W., Herman C. J. Cell volumes and DNA distribution s of normal and neoplastic lymphoid cells. Cancer 1978; 41: 201–209
   PubMed Web of Science ®Google Scholar
• Scarffe J. H., Crowther D. The pre-treatment proliferative activity of non–Hodgkin's lymphoma cells. Eur J Cancer. 1981; 17: 99–108
   PubMed Web of Science ®Google Scholar
• Gerdes L., Dellenbach F., Lennert K., Lemke H., Stein H. Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody K167. Hematol. Oncol. 1984; 2: 365–371
   PubMedGoogle Scholar
• Gerdes J., Stein H., Pileri S., Rivano M. T., Gobbi M., Ralkfiaer E., Nielsen K. M., Pallesen G., Bartles H., Palestro G., Delsol G. Prognostic relevance of tumor-cell growth fraction in malignant non-Hodgkin's lymphomas. Lancet 1987; 2: 488
   PubMedGoogle Scholar
• Grogan T. M., Lippman S. M., Spier C. M., Slymen D. J., Rybski J. A., Rangel C. S., Richter L. C., Miller T. P. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphoma as determined by the monoclonal antibody K167. Blood 1988; 71: 1157–1160
   PubMed Web of Science ®Google Scholar
• Holte H., De Lange Davies C., Beiske K., Stokke T., Marton P. F., Smeland E. B., Hoie J., Kvaloy S. Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumor progression in low-grade B-cell lymphoma. Int J. Cancer. 1989; 44: 975–980
   PubMed Web of Science ®Google Scholar
• Srigley J., Barlogie B., Butler J. J., Osborne B., Blick M., Johnston D., Kantarjian H., Reuben J., Batsakis J., Freireich E. J. Heterogeneity of non-Hodgkin's lymphoma probed by nuclei acid cytometry. Blood 1985; 65: 1090–1096
   PubMed Web of Science ®Google Scholar
• McLaughlin P., Osborne H. M., Johnston D., Jennings P., Butler J. J., Cabanillas F., Barlogie B. Nucleic acid cytometry in large cell lymphoma. Cancer Res. 1988; 38: 6614–6619
   Google Scholar
• Lehtinen T., Aine R., Lehtinen M., Kallioniemi O. P., Leino T., Hakala T., Leinikki P., Alavaikko M. Flow cytometric DNA analysis of 199 histologically favourable or unfavourable non-Hodgkin's lymphomas. J. Pathol. 1989; 157: 27–36
   PubMed Web of Science ®Google Scholar
• Diamond L. W., Brylan R. C. Flow analysis of DNA content and cell size in non-Hodgkin's lymphoma. Cancer Res. 1980; 40: 703–712
   PubMed Web of Science ®Google Scholar
• Shackney S. E., Levine A. M., Fisher R. I., Nichols P., Jaffe E., Schuette W. H., Simon R., Smith C. A., Occhipinti S. J., Parker I. W., Cossman J., Young R. C., Lukes R. J. The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study in 220 cases. J. Clin. Invest. 1984; 73: 1201–1214
   PubMed Web of Science ®Google Scholar
• Wooldridge T. N., Grierson H. L., Weisenburger D. D., Armitage J. O., Sanger W. G., Collins M. M., Pierson J. L., Panza M. E., Fordyce R., Purtilo D. T. Association of DNA content and proliferative activity with clinical outcome in patients with diffuse mixed cell and large cell non-Hodgkin's lymphoma. Cancer Res. 1988; 48: 6608–6613
   PubMed Web of Science ®Google Scholar
• Young A. R., Hedley D. W., Rugg C. A., Iland H. J. The prognostic significance of proliferative activity in poor histology non-Hodgkin's lymphoma: a flow cytometric study using archival material. Eur. J. Cancer 1987; 23: 1947–1504
   Google Scholar
• Egerter D. A., Said J. W., Epling S., Lee S. DNA content of T-cell lymphomas. A flow-cytometric analysis. Am. J. Pathol. 1988; 130: 326–334
   PubMed Web of Science ®Google Scholar
• Koss L. G., Czerniak B., Herz F., Wersto R. Flow cytometric measurement of DNA and other cell components in human tumors: a critical appraisal. Human Pathol. 1989; 20: 528–548
   PubMed Web of Science ®Google Scholar
• Crocker J. Proliferation indices in malignant lymphomas. Clin. Exp. Immunol. 1989; 77: 299–308
   PubMed Web of Science ®Google Scholar
• Gerdes J., Schwab U., Lemke H., Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 1983; 31: 13–20
   PubMed Web of Science ®Google Scholar